MediWound (MDWD)
(Delayed Data from NSDQ)
$18.24 USD
+0.58 (3.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.16 -0.08 (-0.44%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for MediWound Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 42 | 34 | 11 | 22 | 29 |
Receivables | 5 | 10 | 3 | 3 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 2 | 1 | 1 | 2 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 50 | 46 | 15 | 26 | 36 |
Net Property & Equipment | 9 | 2 | 2 | 3 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 66 | 50 | 20 | 31 | 41 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 6 | 6 | 5 | 3 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 6 | 6 | 5 | 6 |
Total Current Liabilities | 11 | 12 | 11 | 8 | 10 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 18 | 26 | 12 | 13 | 12 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 35 | 39 | 24 | 24 | 25 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 206 | 179 | 144 | 142 | 141 |
Retained Earnings | -175 | -168 | -149 | -135 | -126 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 32 | 11 | -5 | 7 | 15 |
Total Liabilities & Shareholder's Equity | 66 | 50 | 20 | 31 | 41 |
Total Common Equity | 32 | 11 | -5 | 7 | 15 |
Shares Outstanding | 9.20 | 7.20 | 3.80 | 3.80 | 3.80 |
Book Value Per Share | 3.43 | 1.52 | -1.21 | 1.91 | 3.99 |
Fiscal Year End for MediWound Ltd falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 42 | 46 | 51 | 57 |
Receivables | NA | 5 | 4 | 4 | 4 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 4 | 3 | 3 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 50 | 53 | 58 | 63 |
Net Property & Equipment | NA | 9 | 6 | 5 | 4 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 66 | 67 | 64 | 69 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 6 | 4 | 4 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 5 | 5 | 6 |
Total Current Liabilities | NA | 11 | 8 | 8 | 9 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 20 | 20 | 25 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 35 | 34 | 29 | 35 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 206 | 0 | 206 | 0 |
Retained Earnings | NA | -175 | 0 | -171 | 0 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 32 | 33 | 35 | 33 |
Total Liabilities & Shareholder's Equity | NA | 66 | 67 | 64 | 69 |
Total Common Equity | 0 | 32 | 33 | 35 | 33 |
Shares Outstanding | 9.40 | 9.20 | 9.20 | 9.20 | 9.20 |
Book Value Per Share | 0.00 | 3.43 | 3.59 | 3.80 | 3.62 |